# Maximus

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/maximus

- Industry: Healthcare
- Headquarters: Santa Monica, US
- Website: www.maximustribe.com
- Total disclosed funding: $14M
- Latest round: Series A (Jul 19, 2022)
- Investors on record: 13

## About

Founded in 2019, and based in California, US, Maximus Health, Inc., a.k.a Maximus operates as a consumer telemedicine company that primarily helps men by offering prescription medication capsules for hormone optimization. In May 2021, Maximus Health, Inc. raised USD 5 million co-led by new investors 8VC and Founders Fund, with participation from other new investors 10X Capital, Abstract Ventures, Correlation Ventures, ONEVC, and Unshackled Ventures. Additionally, in July 2022, Maximus Health raised USD 9.08 million in Series A funding led by returning investor Founders Fund, with participation from new investors Chamaeleon, Electric Ant Lab B.V., Gaingels Syndicate, Rational Ventures, Shrug Capital, and What If Ventures. Returning investors and individual investors also participated in the round. The Series A funding valued the company at USD 36.06 million post-money.

Maximus provides at-home lab testing and doctor-prescribed programs to optimize men’s health and hormone function. The company's products include The King Protocol through which customers can use prescription medication and health coaching to optimize natural testosterone production with pills, testosterone replacement therapy, injectables, or controlled substances; The Lover Protocol, a combination of prescription medications that enhances blood flow and libido to improve both sexual performance and enjoyment; The Warrior Protocol which is a combination of prescription ingredients to help reduce hair loss and promote hair growth; and Maximus Building Blocks which include prescription-strength dosages and bioavailable forms of 15 key vitamins and minerals for optimal hormone production. Moreover, the telehealth consultations are conducted by a board-certified physician with knowledge and experience in men’s health. As of 2022, Maximus is available in the U.S. states, except Alabama, Alaska, Indiana, and the District of Columbia.  

Maximus generates revenue through at-home lab tests that are part of the King protocol program, which costs USD199 a month for the doctor’s visit, coaching, and medication. Lover protocol costs USD 149 a month and includes doctor consultations, medication, and coaching.   

The company plans to use the 2022 proceeds to expand access, grow brand awareness, and invest in product development.

## Funding rounds

- Series A, Jul 19, 2022, $9.1M — Founders Fund, Correlation Ventures, Unshackled Ventures, 8VC, Gaingels, Abstract Ventures, Shrug Capital, ONEVC, 10X Capital, What If Ventures, Chamaeleon, Rational Ventures, Electric Ant Lab B.V.
- Seed, May 31, 2021, $5M — Founders Fund, Correlation Ventures, Unshackled Ventures, 8VC, Abstract Ventures, ONEVC, 10X Capital

## Investors

- Founders Fund (https://capitalatlas.ai/funds/founders-fund) — Seed, Series A
- Correlation Ventures (https://capitalatlas.ai/funds/correlation-ventures) — Seed, Series A
- Unshackled Ventures (https://capitalatlas.ai/funds/unshackled-ventures) — Seed, Series A
- 8VC (https://capitalatlas.ai/funds/8vc) — Seed, Series A
- Abstract Ventures (https://capitalatlas.ai/funds/abstract-ventures) — Seed, Series A
- ONEVC (https://capitalatlas.ai/funds/onevc) — Seed, Series A
- 10X Capital (https://capitalatlas.ai/funds/10x-capital) — Seed, Series A
- Gaingels (https://capitalatlas.ai/funds/gaingels) — Series A
- Shrug Capital (https://capitalatlas.ai/funds/shrug-capital) — Series A
- What If Ventures (https://capitalatlas.ai/funds/what-if-ventures) — Series A
- Chamaeleon (https://capitalatlas.ai/funds/chamaeleon) — Series A
- Rational Ventures (https://capitalatlas.ai/funds/rational-ventures) — Series A
- Electric Ant Lab B.V. — Series A